Passage Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	33.34	46.3	37.57	21.71	34.6	128.97
Short-Term Investments	-	-	39.18	92.59	155.01	186.81
Cash & Short-Term Investments	33.34	46.3	76.76	114.29	189.61	315.77
Cash Growth	-47.38%	-39.67%	-32.84%	-39.72%	-39.95%	3.59%
Other Current Assets	1.41	1.46	2.06	3.67	7.43	9.29
Total Current Assets	34.74	47.76	78.82	117.96	197.04	325.07
Net Property, Plant & Equipment	1.48	14.28	23.13	32.15	42.24	23.81
Other Long-Term Assets	0.24	0.24	0.46	0.43	4.27	6.2
Total Assets	36.46	62.28	102.41	150.55	243.55	355.08
Accounts Payable	1.31	1.11	0.74	1.3	4.07	9.45
Accrued Expenses	3.9	4.65	6.71	11.67	11.01	20.05
Current Portion of Leases	1.15	3.57	3.69	3.37	3.28	-
Unearned Revenue	13.75	13.75	8.23	-	-	-
Total Current Liabilities	20.1	23.08	19.36	16.34	18.35	29.5
Long-Term Leases	4.61	20.44	21.79	22.92	23.83	-
Other Long-Term Liabilities	-	-	-	-	-	6.92
Total Long-Term Liabilities	4.61	20.44	21.79	22.92	23.83	6.92
Total Liabilities	24.71	43.53	41.15	39.26	42.18	36.42
Common Stock	-	-	-	0.01	0.01	0.01
Additional Paid-in Capital	724.07	723.51	720.49	705.79	694.73	675.35
Accumulated Other Comprehensive Income	-	0.01	-	-0.04	-0.97	-0.41
Retained Earnings	-712.32	-704.76	-659.24	-594.47	-492.41	-356.28
Shareholders' Equity	11.75	18.76	61.25	111.28	201.37	318.66
Total Liabilities & Equity	36.46	62.29	102.4	150.55	243.55	355.08
Total Debt	5.76	24.01	25.48	26.29	27.11	0
Net Cash (Debt)	27.58	22.29	51.28	88	162.5	315.77
Net Cash Growth	23.72%	-56.53%	-41.73%	-45.85%	-48.54%	3.59%
Net Cash Per Share	8.66	7.03	16.66	32.15	59.71	118.39
Book Value	11.75	18.76	61.25	111.28	201.37	318.66
Book Value Per Share	3.69	5.91	19.90	40.66	73.99	119.47
Tangible Book Value	11.75	18.76	61.25	111.28	201.37	318.66
Tangible Book Value Per Share	3.69	5.91	19.90	40.66	73.99	119.47

SEC Filings: 10-K · 10-Q